Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
- PMID: 35912744
- PMCID: PMC9535569
- DOI: 10.3233/JAD-220369
Incidence and Outcomes of SARS-CoV-2 Infection in Older Adults Living with Dementia: A Population-Based Cohort Study
Abstract
Background: The identification of risk factors for SARS-CoV-2 infection and mortality in patients with dementia is a key aspect to support clinical decisions and public health interventions.
Objective: To assess the incidence of SARS-CoV-2 infection and COVID-19 related death in a cohort of patients with dementia residing in the Lazio region and to investigate predicting factors for both infection and mortality.
Methods: This population-based study used information from administrative databases and the SARS-CoV-2 infection surveillance system. Patients with dementia (age ≥65) were enrolled as of December 31, 2019 and followed-up until February 28, 2021. Cumulative risk of infection and death within 60 days of infection onset, and age-standardized incidence (SIR) and mortality (SMR) ratios were calculated. Logistic regression models were applied to identify factors associated with infection and mortality.
Results: Among 37,729 dementia patients, 2,548 had a diagnosis of SARS-CoV-2 infection. The crude risk of infection was 6.7%. An increase in risk of infection was observed both in women (SIR 1.72; 95% CI 1.64-1.80) and men (SIR 1.43; 95% CI 1.33-1.54). Pneumonia, cerebrovascular and blood diseases, femur fracture, anxiety, antipsychotic and antithrombotic use were associated with an increased risk of infection. The crude risk of death was 31.0%, the SMRs 2.32 (95% CI 2.05-2.65) for men, and 2.82 (95% CI 2.55-3.11) for women. Factors associated with mortality included: male gender, age ≥85, symptoms at the diagnosis, antipsychotic and systemic antibiotics treatment.
Conclusion: These findings emphasize the need of close and tailored monitoring of dementia patients to reduce the impact of COVID-19 on this fragile population.
Keywords: Administrative databases; Alzheimer’s disease; COVID-19; SARS-CoV-2 infection; cohort study; dementia; prognostic factors.
Conflict of interest statement
Authors’ disclosures available online (
Figures
Similar articles
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Risk factors associated with COVID-19 infection and mortality in nursing homes.Aten Primaria. 2022 Oct;54(10):102463. doi: 10.1016/j.aprim.2022.102463. Epub 2022 Sep 6. Aten Primaria. 2022. PMID: 36148713 Free PMC article.
-
Effect of long-term care and pandemic wave on relative risk of COVID-19-related infection, hospitalization and mortality in people living with dementia: A population-based cohort study.J Alzheimers Dis. 2025 Apr;104(3):777-791. doi: 10.1177/13872877251319560. Epub 2025 Mar 25. J Alzheimers Dis. 2025. PMID: 40134262
-
Association between COVID-19 infection and new-onset dementia in older adults: a systematic review and meta-analysis.BMC Geriatr. 2024 Dec 15;24(1):940. doi: 10.1186/s12877-024-05538-5. BMC Geriatr. 2024. PMID: 39674870 Free PMC article.
-
Dementia as a mortality predictor among older adults with COVID-19: A systematic review and meta-analysis of observational study.Geriatr Nurs. 2021 Sep-Oct;42(5):1230-1239. doi: 10.1016/j.gerinurse.2021.03.007. Epub 2021 Mar 14. Geriatr Nurs. 2021. PMID: 33824009 Free PMC article.
Cited by
-
Frequency and burden of neurological manifestations upon hospital presentation in COVID-19 patients: Findings from a large Brazilian cohort.J Neurol Sci. 2022 Dec 15;443:120485. doi: 10.1016/j.jns.2022.120485. Epub 2022 Nov 9. J Neurol Sci. 2022. PMID: 36375382 Free PMC article.
-
Impact of COVID-19 on functional, cognitive, neuropsychiatric, and health-related outcomes in patients with dementia: A systematic review.eNeurologicalSci. 2024 Nov 21;38:100539. doi: 10.1016/j.ensci.2024.100539. eCollection 2025 Mar. eNeurologicalSci. 2024. PMID: 39720103 Free PMC article. Review.
-
Dementia and psychotropic medications are associated with significantly higher mortality in geriatric patients hospitalized with COVID-19: data from the StockholmGeroCovid project.Alzheimers Res Ther. 2023 Jan 6;15(1):5. doi: 10.1186/s13195-022-01154-w. Alzheimers Res Ther. 2023. PMID: 36609457 Free PMC article.
-
Prevalence and economic burden of dementia in the Arab world.BJPsych Open. 2023 Jul 13;9(4):e126. doi: 10.1192/bjo.2023.517. BJPsych Open. 2023. PMID: 37439065 Free PMC article.
-
A new national survey of centers for cognitive disorders and dementias in Italy.Neurol Sci. 2024 Feb;45(2):525-538. doi: 10.1007/s10072-023-06958-8. Epub 2023 Aug 18. Neurol Sci. 2024. PMID: 37592124 Free PMC article.
References
-
- Dorrucci M, Minelli G, Boros S, Manno V, Prati S, Battaglini M, Corsetti G, Andrianou X, Riccardo F, Fabiani M, Vescio MF, Spuri M, Urdiales AB, Manso M, Onder G, Pezzotti P, Bella Aon behalf of the Italian Integrated Surveillance COVID-19 group(2021) Excess mortality in Italy during the COVID-19 pandemic: Assessing the differences between the first and the second wave, year 2020. Front Public Health 9, 669209. - PMC - PubMed
-
- Canevelli M, Palmieri L, Raparelli V, Lo Noce C, Colaizzo E, Tiple D, Vaianella L, Vanacore N, Brusaferro S, Onder G, Italian NationalInstitute of Health COVID-19 Mortality Group (2020) Prevalenceand clinical correlates of dementiaamong COVID-19-related deaths in Italy. Alzheimers Dement(Amst) 12, e12114. - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous